Skip to content

Could this Alzheimer's vaccine cut dementia cases in half?

Robert Hohler, owner of Companions of London, writes about whether a new alzheimer's vaccine could help treat dementia.

Could this Alzheimer's vaccine cut dementia cases in half?
Published: | 4 min read

Robert Hohler, owner of Companions of London, writes about whether a new alzheimer's vaccine could help treat dementia. 

Alzheimer's

Alzheimer's disease (AD) is a chronic neurodegenerative disease — one that starts slowly and progresses over time. It is the most common form of dementia, and the first signs of Alzheimer’s include difficulties with language, mood swings, disorientation, loss of motivation, problems with self-care and behavioural issues. As the condition escalates, family members and friends see the patient retreat into themselves and withdraw from society. This disease is traumatising for the individual and everyone around them — the typical life expectancy following diagnosis is generally three to nine years.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information